drive safety.
Companies mentioned include:
Athersys, Inc. (ATHX) - $1.68 - Buy
Baxter (BAX)- $69.88 - NR
Capricor (private)
Cardio3 Biosciences (private)
Cytomedix (CMXI) - $0.42 - NR
Cytori Therapeutics (CY7X)- $2.43 - Buy
Dendreon (DNDN ... allogeneic (and xenogeneic) MultiStem in immune-
competent animal models of disease and injury.
Capricor, Inc. (private) is a unique company in the cardiovascular space. The company has transitioned
from ... heart that is destined to become cardiac cells. In its phase I "CADUCES" trial, Capricor
has shown its autologous cardiosphere-derived stem cells (CDC) reduce infarct size and generate